Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes
Open Access
- 1 June 2015
- journal article
- research article
- Published by Bioscientifica in Endocrine Connections
- Vol. 4 (2) , 92-99
Abstract
Objective: Dysfunction of the hypothalamus–pituitary–adrenal (HPA) axis has been implicated in type 2 diabetes (T2D). The aim of this study was to investigate the impact of T2D and gender on the HPA axis.Methods: Synthetic ACTH (1 μg) was administered to 21 subjects with T2D (age 62 (54–70) years, 11 men/ten women, HbA1c 49±2 mmol/mol, treated with diet or oral antidiabetic drugs) and 38 controls (age 58 (41–67) years, 20 men/18 women). Fasting basal B-glucose, serum cortisol, insulin, IGF1 and IGFBP1 concentrations were measured, and sampling for all but IGF1 was repeated 30, 60, and 90 min after ACTH injection. Patients took 0.25 mg dexamethasone at 2200–2300 h and returned the next morning for the measurement of serum cortisol concentration.Design: Cross-sectional study.Results: Patients with T2D had similar fasting serum cortisol, IGF1 and IGFBP1 concentrations; however, serum cortisol concentration after administration of dexamethasone did not differ between the groups. Healthy women exhibited higher peak cortisol levels compared with healthy men (675±26 vs 582±21 nmol/l, P=0.014), while the peak levels were equally high in men and women with T2D, resulting in a higher peak level in men with T2D compared with healthy men (691±42 vs 582±21 nmol/l, P=0.024). Serum cortisol concentration after administration of dexamethasone did not differ between the groups, nor did IGF1 and IGFBP1.Novelty of the findings: Some studies have previously indicated disturbed regulation of the hypothalamus–pituitary–adrenal (HPA) axis in subjects with type 2 diabetes (T2D); however, much remains unknown in this area. To the best of our knowledge, this is the first study to show that the gender difference in the adrenal response to ACTH (with greater reactivity in women) is abolished in T2D. While the clinical implications cannot be determined by this paper, it is known that gender differences exist in the pathogenesis and complications of T2D. Thus, our findings suggest that further research into gender differences in the HPA axis is warranted.Conclusions: Gender differences in adrenal response to ACTH were abolished in T2D. Men with T2D had a higher peak cortisol compared with controls. Further studies are needed to elucidate the clinical implications.Keywords
This publication has 34 references indexed in Scilit:
- Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysisGrowth Hormone & IGF Research, 2010
- IGF-I Bioactivity in an Elderly PopulationDiabetes, 2010
- Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetesClinical Science, 2008
- The low dose dexamethasone suppression test: Effect of time of administration and doseJournal of Endocrinological Investigation, 2002
- The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causesInternational Journal of Obesity, 2000
- Neuroendocrine perturbations as a cause of insulin resistanceDiabetes/Metabolism Research and Reviews, 1999
- On the meaning of low-dose ACTH(1-24) tests to assess functionality of the hypothalamic-pituitary-adrenal axisEuropean Journal of Endocrinology, 1999
- Interperson Variability but Intraperson Stability of Baseline Plasma Cortisol Concentrations, and Its Relation to Feedback Sensitivity of the Hypothalamo-Pituitary-Adrenal Axis to a Low Dose of Dexamethasone in Elderly Individuals1The Journal of Clinical Endocrinology & Metabolism, 1998
- The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.1992
- Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluidEuropean Journal of Endocrinology, 1984